STAT3-IN-B9

STAT3-IN-B9 (B9) is a small molecule inhibitor that selectively targets aberrant STAT3 activation. It demonstrates potent anti-proliferative effects in various cancer cell lines, including MDA-MB-468, MDA-MB-231, and DU145, making it a valuable tool for in vitro and in vivo oncology research focused on STAT3 signaling pathways.